Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OMM Scientific is a small U.S.-based chemistry-focused life sciences company that develops early-stage technologies, sells specialty research products, and provides collaborative custom synthesis services for biotech and biopharma customers. The company positions itself around "Chemistry for Life Sciences" and works across drug discovery, process development, analytical method development, and production from milligram to kilogram scale. Its disclosed internal and co-developed technology efforts include QseC antagonists aimed at antivirulence treatment of Gram-negative bacterial pathogens, a novel 2'O-protecting group for chemical RNA synthesis, and a surface plasmon coupled emission platform for ultrasensitive microRNA sensing. OMM Scientific also markets specialty chemical research tools such as autoinducer-related compounds and eicosanoid products. Overall, it appears to operate more as a chemistry-enabling and pre-seed technology development company than as a traditional clinical-stage therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OMM.